Publisher
Springer Science and Business Media LLC
Reference12 articles.
1. Hodi, F. S. et al. Improved survival with ipilimumab in patients with metastatic melanoma. N. Engl. J. Med. 363, 711–723 (2010).
2. Schadendorf, D. et al. Pooled analysis of long-term survival data from phase II and phase III trials of ipilimumab in unresectable or metastatic melanoma. J. Clin. Oncol. 33, 1889–1894 (2015).
3. Hellmann, M. D., Kris, M. G. & Rudin, C. M. Medians and milestones in describing the path to cancer cures: telling “tails”. JAMA Oncol. 2, 167–168 (2016).
4. Schilsky, R. L. & Schnipper, L. E. Hans Christian Andersen and the value of new cancer treatments. J. Natl Cancer Inst.
https://doi.org/10.1093/jnci/djx261
(2017).
5. Slomiany, M. et al. Value Frameworks in oncology: comparative analysis and implications to the pharmaceutical industry. Am. Health Drug Benefits 10, 253–260 (2017).
Cited by
132 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献